Department of Respiratory Medicine, University Hospital Jean Minjoz, Besançon, France.
Medical Department of Vaincre La Mucoviscidose, Paris, France.
PLoS One. 2019 Jan 8;14(1):e0210201. doi: 10.1371/journal.pone.0210201. eCollection 2019.
Pseudomonas aeruginosa is the main cause of chronic airway infection in cystic fibrosis (CF). However, for unclear reasons some patients are never colonized by P. aeruginosa. The objectives of this study were to better define the clinical, genetic, and microbiological characteristics of such a subpopulation and to identify predictive factors of non-colonization with P. aeruginosa. The French CF patient registry 2013-2014 was used to identify CF patients aged ≥ 20 years. The clinical outcomes, CF Transmembrane conductance Regulator (CFTR) genotypes, and microbiological data of patients reported positive at least once for P. aeruginosa ("Pyo" group, n = 1,827) were compared to those of patients with no history of P. aeruginosa isolation ("Never" group, n = 303). Predictive factors of non-colonization by P. aeruginosa were identified by multivariate logistic regression model with backward selection. Absence of aspergillosis (odds ratio (OR) [95% CI] = 1.64 [1.01-2.66]), absence of diabetes (2.25 [1.21-4.18]), pancreatic sufficiency (1.81 [1.30-2.52]), forced expiratory volume 1 (FEV1) ≥ 80% (3.03 [2.28-4.03]), older age at CF diagnosis (1.03 [1.02-1.04]), and absence of F508del/F508del genotype (2.17 [1.48-3.19]) were predictive clinical factors associated with absence of infection ("Never" group). Microbiologically, this same group was associated with more frequent detection of Haemophilus influenzae and lower rates of Stenotrophomonas maltophilia, Achromobacter xylosoxidans and Aspergillus spp. (all p<0.01) in sputum. This study strongly suggests that the absence of pulmonary colonization by P. aeruginosa in a minority of CF adults (14.2%) is associated with a milder form of the disease. Recent progress in the development of drugs to correct CFTR deficiency thus may be decisive in the control of P. aeruginosa lung infection.
铜绿假单胞菌是囊性纤维化(CF)慢性气道感染的主要原因。然而,由于原因不明,有些患者从未被铜绿假单胞菌定植。本研究的目的是更好地定义这种亚群的临床、遗传和微生物学特征,并确定非定植于铜绿假单胞菌的预测因素。使用法国 CF 患者登记 2013-2014 年,确定年龄≥20 岁的 CF 患者。比较至少一次报告铜绿假单胞菌阳性(“Pyo”组,n=1827)和无铜绿假单胞菌分离史的患者(“从未”组,n=303)的临床结局、CF 跨膜电导调节剂(CFTR)基因型和微生物学数据。通过向后选择的多变量逻辑回归模型识别非定植于铜绿假单胞菌的预测因素。无曲霉菌病(比值比(OR)[95%CI]=1.64[1.01-2.66])、无糖尿病(2.25[1.21-4.18])、胰腺充足(1.81[1.30-2.52])、用力呼气量 1(FEV1)≥80%(3.03[2.28-4.03])、CF 诊断时年龄较大(1.03[1.02-1.04])和无 F508del/F508del 基因型(2.17[1.48-3.19])是与感染缺失相关的预测临床因素(“从未”组)。微生物学上,同一组与痰液中更频繁地检测到流感嗜血杆菌和更低的嗜麦芽寡养单胞菌、木糖氧化无色杆菌和曲霉菌属的发生率相关(均 p<0.01)。本研究强烈表明,少数 CF 成年患者(14.2%)肺部未被铜绿假单胞菌定植与疾病的较轻形式有关。纠正 CFTR 缺陷的药物的最新进展可能对控制铜绿假单胞菌肺部感染具有决定性意义。